MarketBeatTue, 19 May 2026 14:15:48 GMTACADIA Pharmaceuticals Spotlights Alzheimer's Psychosis Pipeline, NUPLAZID and DAYBUE GrowthACAD+1.77%
Seeking AlphaWed, 13 May 2026 02:10:54 GMTACADIA Pharmaceuticals Inc. (ACAD) Presents at Bank of America Global Healthcare Conference 2026 TranscriptACAD+1.77%
MarketBeatWed, 13 May 2026 00:25:12 GMTACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data LoomsACAD+1.77%
Zacks Investment ResearchThu, 07 May 2026 16:46:29 GMTACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales GrowthACAD+1.77%
Seeking AlphaThu, 07 May 2026 08:41:24 GMTACADIA Pharmaceuticals Inc. (ACAD) Q1 2026 Earnings Call TranscriptACAD+1.77%
Zacks Investment ResearchWed, 06 May 2026 22:25:47 GMTAcadia Pharmaceuticals (ACAD) Lags Q1 Earnings and Revenue EstimatesACAD+1.77%
Zacks Investment ResearchThu, 30 Apr 2026 16:40:27 GMTCSLLY vs. ACAD: Which Stock Is the Better Value Option?ACAD+1.77%
Zacks Investment ResearchThu, 30 Apr 2026 15:01:42 GMTIovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseACAD+1.77%
Zacks Investment ResearchWed, 29 Apr 2026 15:01:47 GMTAcadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?ACAD+1.77%
Zacks Investment ResearchTue, 14 Apr 2026 16:40:29 GMTCSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?ACAD+1.77%
Zacks Investment ResearchWed, 08 Apr 2026 17:10:27 GMTWill Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?ACAD+1.77%
Zacks Investment ResearchFri, 27 Mar 2026 16:32:16 GMTWhy Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?ACAD+1.77%
Zacks Investment ResearchMon, 09 Mar 2026 16:40:41 GMTJAZZ or ACAD: Which Is the Better Value Stock Right Now?ACAD+1.77%
Zacks Investment ResearchThu, 05 Mar 2026 11:10:15 GMTACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)ACAD+1.77%
Zacks Investment ResearchWed, 04 Mar 2026 14:05:46 GMTACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EUACAD+1.77%
Seeking AlphaSat, 28 Feb 2026 13:58:59 GMTAcadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline KickerACAD+1.77%
Zacks Investment ResearchThu, 26 Feb 2026 15:56:55 GMTACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue GrowthACAD+1.77%
Seeking AlphaThu, 26 Feb 2026 06:57:48 GMTACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call TranscriptACAD+1.77%
Zacks Investment ResearchThu, 26 Feb 2026 01:25:42 GMTAcadia Pharmaceuticals (ACAD) Q4 Earnings Top EstimatesACAD+1.77%
